National Quantum Stock Exchange has filed for an IPO on the Science and Technology Innovation Board, aiming to raise 11.69 billion yuan.

On December 10th, Guoyi Quantum Technology (Hefei) Co., Ltd. (Guoyi Quantum) has submitted its application for an IPO on the Shanghai Stock Exchange's Sci-Tech Innovation Board. Huatai United Securities serves as the sponsor institution, with plans to raise 1.169 billion yuan. According to the prospectus, Guoyi Quantum has been focusing on the research and development of high-end scientific instruments since its establishment. It serves various fields such as quantum technology, materials science, chemical engineering, biomedicine, and advanced manufacturing, providing high-end scientific instrument equipment needed for cutting-edge scientific exploration to universities, research institutes, and enterprises worldwide. The company's core key devices include enhanced quantum sensors and solutions, actively contributing to solving key technological challenges. Globally, the scientific instrument market is showing a trend towards high concentration, with European and American companies dominating the market with their technological expertise and brand advantages, particularly in the field of high-precision and complex high-end instruments where international giants almost monopolize the market. With the Chinese government's emphasis on technological innovation and high-end manufacturing, as well as the rapid development of downstream industries such as biomedicine, semiconductors, and new materials, the demand for high-end scientific instruments in China continues to grow. However, the domestic localization rate remains low, with a high reliance on imports. Domestic companies are gradually narrowing the gap with international giants through technological breakthroughs and product upgrades. Since its establishment, Guoyi Quantum has actively participated in domestic and international market competition and launched products such as electron paramagnetic resonance spectrometers, scanning NV probe microscopes, field-emission scanning electron microscopes, and focused ion beam electron dual-beam microscopes, whose core performance indicators have reached or even surpassed those of international competitors. The company is gradually breaking the long-term monopoly or dominance of international giants in the domestic high-end scientific instrument market and ranks among the top in sub-markets such as quantum information and spin resonance and electron microscopy. Additionally, the company is an explorer and practitioner of quantum technology, introducing a series of quantum information technology products such as quantum diamond single-spin spectrometers and wide-field NV microscopes based on NV color center sensors and optically detected magnetic resonance technology. These products have significantly higher sensitivity, precision, resolution, and imaging capabilities compared to traditional measurement technologies, representing a major disruptive technological innovation with significant scientific and strategic value. The funds raised in this offering will be invested in projects approved at the company's third extraordinary shareholder meeting in 2025, to be implemented by the board of directors. In terms of finances, Guoyi Quantum is expected to achieve operating revenues of approximately 151 million yuan, 400 million yuan, 501 million yuan, and 171 million yuan in the fiscal years 2022, 2023, 2024, and the first 6 months of 2025, respectively. Meanwhile, the corresponding net profits attributable to the parent company are projected to be -123 million yuan, -140 million yuan, -74.08 million yuan, and -72.57 million yuan, respectively.